猪鸡肠道益生菌株的分离鉴定及其抗TGEV和IBV的作用
|
摘要
本实验从健康的雏鸡和仔猪盲肠中分离鉴定出三株益生菌,采用MTT和细胞病变方法,分别在鸡胚成纤维细胞(CEF)和PK-15细胞模型上初步评价了三株益生菌对TGEV和IBV抑制率的影响,探讨益生菌的抗病毒作用。
实验中首先利用革兰氏染色,生化试验,16Sr RNA,抑菌试验等方法分离鉴定出了三株益生菌,分别命名为:L1—德氏乳杆菌德氏亚种(Lactobacillus.delbrueckiisubsp.delbrueckii)、L2—德氏乳杆菌乳亚种(Lactobacillus.delbrueckii subsplactis)和L3—德氏乳杆菌保加利亚亚种( Lactobacillus delbrueckii subsp. bulgaricus)。利用MTT法测定益生菌处理后的细胞活性,经统计分析得出益生菌对细胞的最大无毒浓度为L1株1011 cfu/ml,L2株1012 cfu/ml,L3株1012 cfu/ml,益生菌培养上清1:2的稀释液,益生菌灭活菌体和破碎菌体成分在实验浓度均未显现细胞毒害现象。
根据上述实验结果开展下列益生菌的抗病毒作用研究。实验分组:第1组:益生菌与上述2种细胞预先分别孵育后再攻毒;第2组:2种细胞感染病毒后再接入益生菌;第3组:益生菌与病毒同时接入细胞;第4组:益生菌对照;第5组:病毒对照;第6组:正常细胞对照。实验结果:以MTT法测定益生菌和病毒(TGEV和IBV)处理后的细胞活性,通过公式计算病毒抑制率。结果表明,无论是在PK-15细胞上,还是在CEF细胞上,益生菌成分和不同加入方式均可显著地提高益生菌对TGEV和IBV的抑制率(P﹤0.05),并且这种作用具有量效关系和时效关系。
益生菌-细胞-病毒相互作用后的细胞病变结果显示,益生菌及其培养上清与TGEV和IBV同时接入细胞可以极显著的阻碍TGEV和IBV引发的细胞病变,推测其可能具有直接的杀灭病毒作用。在实验中,我们分别研究了益生菌活菌、培养上清、灭活菌体和破碎菌体成分的抗病毒作用,结果表明,益生菌的各种形式均具有一定的抗病毒作用,但在效果上存在一定的差异,原因可能是其抗病毒作用的机制不同。益生菌与细胞作用后再感染病毒,对TGEV和IBV抑制率升高的结果反映出了益生菌对TGEV和IBV吸附细胞的阻断作用;从益生菌与病毒同时接入细胞后降低病毒对细胞侵害的现象,可以看出益生菌可能对病毒具有直接破坏作用;细胞感染病毒后再接入益生菌对TGEV和IBV抑制率极低的现象说明,病毒感染后益生菌再很难发挥作用。
综上所述,在体外益生菌对TGEV和IBV细胞病变影响的实验中,所分离的三株益生菌及其培养上清都极显著地阻碍了TGEV和IBV细胞病变程度,但各菌种之间存在程度不同的差异;这一结果说明益生菌可能具有直接破坏病毒的作用,并且具有菌种特异性。初步确定这三株益生菌具有抗病毒作用。益生菌菌株可以直接破坏TGEV和IBV,又可以阻断病毒对细胞的感染、抑制病毒在细胞内的增殖。
In the experiments, Bolting and identify three strains probiotics from cecum of healthy chicken and young swine, apply MTT and cytopathic effect(CPE) method in vitro CEF and PK-15 cell preliminary assessment the effect of the inhibition rate of probiotics to TGEV and IBV, then to draw the antiviral activity of three probiotics and to analyze the possible mechanism.
In experiments, first to utilize Gram staining, biochemistry essay, 16Sr RNA , bacteriostasis essay and so on bolting and identify three strains probiotics is Lactobacillus.delbrueckiisubsp. delbrueckii(L1);Lactobacillus.delbrueckiisubsplactis(L2);Lactobacillus.delbrueckiisubsp.Bulgaricus (L3) .We determined the cell viability after treated by probiotics using MTT and analyzed the largest non-toxic concentration of 1011cfu/ml Lactobacillus casei, 1012cfu/ml of Lactobacillus acidophilus and 1:2 diluted probiotics metabolites, inactivated probiotics and broken products in the experimental concentrations had not appear cell toxicity phenomena.we selected the highest sensitivity antibiotics(gentamicin) on the three probiotics by sensitivity test.
According to the experimental results, we had the anti-virus research of probiotics in cells. Experimental groups as follows: group 1: Pre-treatment of cells with probiotics; Group 2: Cells infected with the virus and then added probiotics; Group 3: Co-incubation of probiotics and NDV; Group 4: Probiotics control; Group 5: Virus control; Group 6: Cells control.
The results showed:We determined the cell activity after probiotics and TGEV and IBV treated by MTT method,and alculated the viral inhibition rate by formula .The results showed that, whether in the PK-15 cell, or in the CEF, probiotics componentcould and different add methods significantly rise the inhibition rate of TGEV and IBV, and had a relationship with concentrations and time.
Cytopathic effect(CPE) of probiotics-cell- virus interaction showed that probiotics and their metabolites added to cells with TGEV and IBV at the same time can reduce the titer of TGEV and IBV significantly, and it indicated that it may have a direct role in killing virus .In the experiment, we studied the antiviral ability of probiotics, metabolites, inactivated probiotics and broken components, results showed that the probiotics in various forms all have some antiviral effect, but there are some differences may be due to the different mechanisms of its antiviral activity .The result of TGEV and IBV inhibition rate rose when pre-treatment of cells with probiotics reflected that the probiotics may block the adsorption of TGEV and IBV on cells; from the phenomenon probiotics and virus added to cells at the same time reduced the harm of virus on cells,we can see that probiotics can play a direct role of damage the virus structure; the phenomenon of lowest inhibition rate of TGEV and IBV when cells infected with TGEV and IBV before probiotics added showed that after the cells infected the probiotics will hard to have effect on virus.
In summary, in the experiment of probiotics on the TGEV and IBV titer in vitro, three probiotics separated and its metabolites were significantly reduced the titer of TGEV and IBV, but there are some differences between strains; the three probiotics separated and their metabolites did not affect the titer of TGEV and IBV, the results indicated that probiotics may have a direct role in destruction of the virus and have strain-specific probiotics not only has a direct role in destruction of the virus, but also can block the virus infected the cells and inhibit the proliferation of virus in cells.
实验中首先利用革兰氏染色,生化试验,16Sr RNA,抑菌试验等方法分离鉴定出了三株益生菌,分别命名为:L1—德氏乳杆菌德氏亚种(Lactobacillus.delbrueckiisubsp.delbrueckii)、L2—德氏乳杆菌乳亚种(Lactobacillus.delbrueckii subsplactis)和L3—德氏乳杆菌保加利亚亚种( Lactobacillus delbrueckii subsp. bulgaricus)。利用MTT法测定益生菌处理后的细胞活性,经统计分析得出益生菌对细胞的最大无毒浓度为L1株1011 cfu/ml,L2株1012 cfu/ml,L3株1012 cfu/ml,益生菌培养上清1:2的稀释液,益生菌灭活菌体和破碎菌体成分在实验浓度均未显现细胞毒害现象。
根据上述实验结果开展下列益生菌的抗病毒作用研究。实验分组:第1组:益生菌与上述2种细胞预先分别孵育后再攻毒;第2组:2种细胞感染病毒后再接入益生菌;第3组:益生菌与病毒同时接入细胞;第4组:益生菌对照;第5组:病毒对照;第6组:正常细胞对照。实验结果:以MTT法测定益生菌和病毒(TGEV和IBV)处理后的细胞活性,通过公式计算病毒抑制率。结果表明,无论是在PK-15细胞上,还是在CEF细胞上,益生菌成分和不同加入方式均可显著地提高益生菌对TGEV和IBV的抑制率(P﹤0.05),并且这种作用具有量效关系和时效关系。
益生菌-细胞-病毒相互作用后的细胞病变结果显示,益生菌及其培养上清与TGEV和IBV同时接入细胞可以极显著的阻碍TGEV和IBV引发的细胞病变,推测其可能具有直接的杀灭病毒作用。在实验中,我们分别研究了益生菌活菌、培养上清、灭活菌体和破碎菌体成分的抗病毒作用,结果表明,益生菌的各种形式均具有一定的抗病毒作用,但在效果上存在一定的差异,原因可能是其抗病毒作用的机制不同。益生菌与细胞作用后再感染病毒,对TGEV和IBV抑制率升高的结果反映出了益生菌对TGEV和IBV吸附细胞的阻断作用;从益生菌与病毒同时接入细胞后降低病毒对细胞侵害的现象,可以看出益生菌可能对病毒具有直接破坏作用;细胞感染病毒后再接入益生菌对TGEV和IBV抑制率极低的现象说明,病毒感染后益生菌再很难发挥作用。
综上所述,在体外益生菌对TGEV和IBV细胞病变影响的实验中,所分离的三株益生菌及其培养上清都极显著地阻碍了TGEV和IBV细胞病变程度,但各菌种之间存在程度不同的差异;这一结果说明益生菌可能具有直接破坏病毒的作用,并且具有菌种特异性。初步确定这三株益生菌具有抗病毒作用。益生菌菌株可以直接破坏TGEV和IBV,又可以阻断病毒对细胞的感染、抑制病毒在细胞内的增殖。
In the experiments, Bolting and identify three strains probiotics from cecum of healthy chicken and young swine, apply MTT and cytopathic effect(CPE) method in vitro CEF and PK-15 cell preliminary assessment the effect of the inhibition rate of probiotics to TGEV and IBV, then to draw the antiviral activity of three probiotics and to analyze the possible mechanism.
In experiments, first to utilize Gram staining, biochemistry essay, 16Sr RNA , bacteriostasis essay and so on bolting and identify three strains probiotics is Lactobacillus.delbrueckiisubsp. delbrueckii(L1);Lactobacillus.delbrueckiisubsplactis(L2);Lactobacillus.delbrueckiisubsp.Bulgaricus (L3) .We determined the cell viability after treated by probiotics using MTT and analyzed the largest non-toxic concentration of 1011cfu/ml Lactobacillus casei, 1012cfu/ml of Lactobacillus acidophilus and 1:2 diluted probiotics metabolites, inactivated probiotics and broken products in the experimental concentrations had not appear cell toxicity phenomena.we selected the highest sensitivity antibiotics(gentamicin) on the three probiotics by sensitivity test.
According to the experimental results, we had the anti-virus research of probiotics in cells. Experimental groups as follows: group 1: Pre-treatment of cells with probiotics; Group 2: Cells infected with the virus and then added probiotics; Group 3: Co-incubation of probiotics and NDV; Group 4: Probiotics control; Group 5: Virus control; Group 6: Cells control.
The results showed:We determined the cell activity after probiotics and TGEV and IBV treated by MTT method,and alculated the viral inhibition rate by formula .The results showed that, whether in the PK-15 cell, or in the CEF, probiotics componentcould and different add methods significantly rise the inhibition rate of TGEV and IBV, and had a relationship with concentrations and time.
Cytopathic effect(CPE) of probiotics-cell- virus interaction showed that probiotics and their metabolites added to cells with TGEV and IBV at the same time can reduce the titer of TGEV and IBV significantly, and it indicated that it may have a direct role in killing virus .In the experiment, we studied the antiviral ability of probiotics, metabolites, inactivated probiotics and broken components, results showed that the probiotics in various forms all have some antiviral effect, but there are some differences may be due to the different mechanisms of its antiviral activity .The result of TGEV and IBV inhibition rate rose when pre-treatment of cells with probiotics reflected that the probiotics may block the adsorption of TGEV and IBV on cells; from the phenomenon probiotics and virus added to cells at the same time reduced the harm of virus on cells,we can see that probiotics can play a direct role of damage the virus structure; the phenomenon of lowest inhibition rate of TGEV and IBV when cells infected with TGEV and IBV before probiotics added showed that after the cells infected the probiotics will hard to have effect on virus.
In summary, in the experiment of probiotics on the TGEV and IBV titer in vitro, three probiotics separated and its metabolites were significantly reduced the titer of TGEV and IBV, but there are some differences between strains; the three probiotics separated and their metabolites did not affect the titer of TGEV and IBV, the results indicated that probiotics may have a direct role in destruction of the virus and have strain-specific probiotics not only has a direct role in destruction of the virus, but also can block the virus infected the cells and inhibit the proliferation of virus in cells.
引文
曹理想. 1999.猪源产细菌素乳酸杆菌的筛选及其生物学特性的研究[D].北京:中国农业大学.
程杰,柳纪省,吴润,等. 2003.猪传染性胃肠炎病毒的分子生物学研究进展[J]. Chinese Journal of Veterinary Science and Technology, 33(12), 36～37.
程伶摘译. 1995.家畜肠道细菌与生产性能的关系[J].国外畜牧技, 22(2): 13～16.
戴国荣,曹国文,姜永康等.2005.不同芽孢杆菌组合对仔猪生产性能的影响[J].营养与饲料,8: 53～54.
方定一, 1980.大肠杆菌对仔猪所致肠道疾病与防治[J].江苏农学报. 1(1): 1～7.
郭崇志,宣振宇. 2002 .人脯氨肽酶活性中心结构的计算机模拟.中国生物化学与分子生物学报, 18 (4) : 499～505.
郭延军.2001.乳杆菌制剂治疗雏鸡白痢效力的研究[J].河北畜牧兽医,17(2): 16～17.
郭云霞,王树香,郝庆红,等. 2009.动物肠道微生态系统及益生菌的营养功能[J].饲料研究, 6: 24～25.
郭兴华. 2002.益生菌基础与应用[M].北京:北京科学技术出版社, 159 : 256～261.
何明清. 1994.动物微生态学[J].北京:中国农业出版社, 48～50.
何明清. 1985.对猪只不同日龄及不同肠段正常菌群的研究[J].畜牧兽医学报, 16(2): 243～249.
何明清. 1994.动物微生态学.农业出版社, 89～95.
何明清. 1984.促菌生防治雏鸡白痢的实验研究及防治效果的观察[J].大连医学院学报, 6 (1): 106～112.
何明清等. 1980.仔猪黄痢及其生物制剂预防方法研究[J] .四川农业科技, 5: 26～28.
何明清,谢镜怀,朱玉兰等. 1985.对鸡只不同日龄不同肠段正常菌群的研究[J] .畜牧兽医学报, 16(5): 22～24.
何昭阳,王增辉,吴延春. 2000.雏鸡消化道主要正常菌群定植规律的研究[J] .畜牧兽医学报, 31(1): 42～48.
黄祯祥主编. 1990.医学病毒学基础及实验技术[J].北京:科学出版社, 151～152.
黄承凤. 1998.饲用益生素[J].中国饲料, 2: 24～25.
黄沧海. 2003.仔猪复合益生乳酸杆菌制剂及其作用机理的研究[D].北京:中国农业大学.
黄海,张清敏,徐建设等. 2009.复合益生菌体外抑菌杀病毒作用研究[J].中国微生态学杂志, 21 (1): 30～35.
金梅林,陈焕春,何启盖等.1998.传染性支气管炎病毒在鸡胚成纤维细胞中适应及复制的生物学特性研究[J].中国兽医杂志, 24(11): 3～4.
金鹏. 2009.益生菌研究进展.农产品加工, 70.
金世琳. 1999.双歧杆菌的功能一健康科学的探索[J].中国乳品工业, 27(3): 41～42.
赖庆安,刘树滔,卢菀华. 2008.鸡氨肽酶H在大肠杆菌中的表达、纯化与部分酶学性质[J].生物工程学报, March 25; 24(3): 381～386.
雷蕾,张日俊. 2008.鸡肠道正常菌群的研究进展. Chinese Journal of Microecology, 20(3): 298～299.
李华, 1999.传染性支气管炎分子生物学研究进展[J].中国兽医杂志, 25(1) : 46~ 48.
李健雄,邝哲师,田兴山. 2004.微生态制剂的研究与应用进展[J].广东畜牧兽医科技, 4: 15～17.
刘冰心,曹敏杰,蔡秋凤,等. 2008.草鱼肌肉亮氨酸氨肽酶的分离纯化与性质研究[J]. 集美大学学报, 13(1): 24～25.
刘博奇,李广兴,王衡,等. 2009.猪传染性胃肠炎病毒特异性受APN功能区的初步鉴定[J].黑龙江畜牧兽医, 21～23.
刘燕,王静慧. 2002.微生态学理论和我国动物微生态制剂研究现状[J].中国兽药杂志, 36 (8) : 38.
罗群力,李静雅,叶其壮,等. 2004.甲硫氨酞氨肤酶的研究进展[J].中国药学杂志, 39(11): 804～805.
明晓波,魏萍. 2008.鸡产染性支气管炎病毒受体的研究进展[J].动物医学进展. 3(29): 82～83.
那日苏,桂荣,等. 2002,牛用益生素的研究与应用[J].饲料研究, 12: 10～13.
那日苏,等. 2004.酵母培养物对绵羊瘤胃发酵及生产性能的影响[J].中国畜牧兽医, 31(1): 6～9.
聂志武. 1998.饲用益生菌[J].中国饲料, 5: 9～10.
潘康成,吕道俊,何明清.正常菌群对动物免疫功能的影响研究[J].
彭勇,李文魁. 1999.国外抗流感病毒植物药研究近况[J].国外医药植物药分册, 14(1): 7～9.
沈志勇,牛钟相,彭军等. 2003.鸡消化道正常菌群的研究进展[J],动物医学进展. 24(6): 61～63.
王君. 2007.微生态制剂研究进展与应用现状[J] .现代畜牧兽医, (1): 52～54.
王桂瑛,刘燕. 2004.益生素的研究及应用进展[J].饲料博览, (6): 4～6.
王健,于景华,张国钮等. 2005.益生菌促生长因子的筛选[J].中国乳品工业, 33(6): 10～12.
王桂瑛,刘燕. 2004.益生素的研究及应用进展[J],饲料博览, 6: 4～6.
王建华. 2005.新型安全饲料添加剂的研制与开发[M].北京:科学技术出版社, 256～262.
温彩霞. 2003.复合型菌剂对鸡白痢菌的抑制作用及其各菌在鸡体内定居情况[J].中国微生态杂志, 5(1): 28～32.
温彩霞. 2002.抗鸡白痢益生菌株的筛选[J].中国微生态杂志, 14(6): 34～36.
吴惠芬,毛胜勇,姚文,等. 2005. 2株猪源乳酸菌对低pH值和胆盐耐受性及热稳定性研究[J] .华中农业大学学报, 24 (3) : 265～268.
吴惠芬. 2003.猪源乳酸菌的分离鉴定及其益生作用研究[D].南京:南京农业大学.
杨景云.肠道菌群与健康肠道微生态学[M].哈尔滨:黑龙江科技出版社, 1991: 135.
殷震主编. 1997.动物病毒学[M] .科学出版社, 675~ 683.
殷震,刘景华. 1997.动物病毒学[M] .第2版.北京:科学出版社, 681～688.
余叶红,郭本恒,吴正钧,等. 2009.干酪乳杆菌LC2W细胞壁组分对RAW264.7巨噬细胞吞噬活性的影响[J].中国微生态学杂志, 21: 123～29.
袁铁铮,姚斌. 2003.分子水平上益生菌研究进展[J].中国生物工程杂志, 24 (10): 27～33.
岳寿松. 2003.微生态制剂对奶牛增奶的实验研究[J].中国奶牛, (3): 20:21.
曾祥伟. 2006. IBV组织嗜性差异分析及其诱导细胞凋亡的研究[D].黑龙江哈尔滨:东北农业大学, 79～81.
张龙涛,冯玉兰,刘波,等.饲用益生菌研究进展[J].食品安全的理论与实践, 275.
张子仪. 2000.中国饲料学[M].北京:中国农业出版社.
张润栋. 1998.活菌制剂在畜禽饲养业中的应用[J].饲料博览, 10(1): 21～25.
赵香汝,赵彦雪,杨玉成. 2005 .中药病毒克颗粒剂对鸡新城疫的预防与治疗效果的观察[J ] .中兽医学杂志, 127(6): 6～7.
Apajalahti, Kettunen, Nurmin, et a. 2003.Selectivep lating underestimetes abundance and shows differential recovery of bifidobacterial species from human feces .[J]. App l Environ Microbiol, 69.
Ariaans M P. 2008. The role of phagocyti cells in enhanced susceptibility of broilers to col ibacillosis after infectious bronchit is virus infection [M]. Vet Immunol Immunopathol, InPress, C or rected Proof , Availab leonline 16 eruary.
AlmazanF, Penze Z. 2001.Cloning of at ransmissible gast roenteritis coronavirus full length cDNA.[J]. Adv Exp Med Biol, 494 : 533～536.
Annuk H, Shchepetova J, Kullisaar T, et al . 2003 . Characterization of intestnal Lactobacilli as putative probiotic candidates[J ]. Journal of Applied Microbiology, 94 : 403～412.
Boursnell M E, et al . 1987. Completion of the sequence of the genome of the coronavirus avian infectious bronchit is virus[ J] . J. Gen.Virol , 68: 57~ 77.
Collinsmd, Gibson G R. 1999. Prebiotics and synbiotics: app roaches formodulation the microbial ccology of the gut [J]. Clin Nutr, 69 (5) : 1052~1057.
Chu V C, Mcelroy L J, Aronson J M, et al. 2007. Feline aminopeptidase N is not a functional receptor for avian infectious bronchitis virus[J].Virology Journal, 4: 20～29.
Chousalkar K K, Roberts J R. 2007. Ultrastructural study of inf ectious bronchit is virus infection in infundibulum and magnum of commercial laying hens .[J] . Vet Microbiol, 122 (3～4): 223～236.
Chen C M, Cavanagh B P. 1995. Cloning and sequencing of a 8.3 kb region f rom the 3′-end of Taiwanese virulent isolate of the coronavirus transmissible gast roenteritis virus[J] . Virus Res , 38 (1) : 83～89.
CrossM.L. 2002. Immunoregulation by Probiotic Lactobacili:Por-Thl singals and their relevnace to humna health. Clin. APPI. Immunol. Rev. 115.
DONSKEY C J, HUJER A M, DAS SM, et al. 2003. Use of denaturing gradient gelelectrophresis for analysis of the stool microbiota of hospintalized Patients [J]. Microbiol Methods, 39 (2) : 249～256.
Dnaiel J.O’Sullivna. 2001. 49. Seerening of intestinal microflora for effctive Probiotie bacteria.J.Agrie. FoodChem. 1751～1760.
Doleyers.Y.2002, 60. Bifibacetrium longumATCC15707 cell Porduction during free and Immobilized-cell culutres in MRS-whey Permeate medium. APPI Mierobiol Bioteehnol. 168～173.
Eiji Ichishima,Youhei Yamagata, Hideki Chiba Kazuyo Sawqguchi,Tomoaki Tanaka. 1989.
Soluble and Bound Forms of Aminopeptidase in Hen’s Egg Yolk.Agric.Biol.Chem [J], 53(7): 1870～1872.
Ehrmann M A , Kurzak P, Bauer J, et al . 2002 . Characterization of lactobacilli towards their use as probiobics adjuncts in poultry[J ] . Journal of Applied Microbiology, 92 : 966～975.
Florenece C G, SandraM L, Bruno B, et al. 2007. Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria[J]. Microbes and Infection , 9: 1623～1631.
Fang S G, Chen N, Felicia P L, et al. 2007. An argininets proline mutation in a domain with undefined functions within the helicase protein (Nsp13) is lethal to the coronavirus infectious bronchit is virus incultured cells[J]. Virology, 358(1) : 136～147.
Florenece C G, SandraM L, Bruno B, et al. 2007. Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria[J]. Microbes and Infection, 9: 1623～1631
Fuller R. 1989. Probiotics in Man and Animals[J]. Appl. Bacterio. 66: 365～378.
Guarnerf, Malageladajr. 2003. Gut flora in health and disease [J]. Lancet, 361: 512～519.
Gregor R. 1999. The scientific basis for probiotic strains of L actobacillus[J] . Applied and Environmental Microbiology, 65(9): 3763～3766.
Harrison S M , Dove B K, Rothw ell L, et al. 2007.Characterisati on of cyclin D1 down or regulation in coronavirus infected cells[J]. FEBS Letters, 581(7) : 1275～1286.
Haberer P, Dutoit M, Dicks L, M, T, Ahrs F. 2003, 27. Eeffet of Potetilly Porbioti Laetobacilli on feacal enzyme aetivity in minipigs on a high fat, highcholesterol dieta perliminary in vivortial. Ini. Food. Miero. l～5 .
Hood S K, Zottola E A. 1988. Effect of low pH on the Ability of Lactobacillus Acidophilus to Survive and Adhere to Human Intestinal Cells[J]. Journal of Food Science. 53: 1514～1516.
Jean Francois E, Denis R, Patnck L, et al . 1995.Complete sequence ( 20 kilobase ) of the Ployprotein encoding gene 1 of transmissible gastroenteritis virus [J]. J Virol , 206 : 817～822.
Kopp HoolihnaL. 2001. prophylaeitic and theraPeutic uses of Probioties[J]. A review Amer, Dlet. Assoe ,101(2): 229～241.
Landend Ijkps, Schutf, Jansen G J, et al. 1995.Quantitative fluorescence in situ hybridation of bifidobacterium spp. with genus specific 16S rRNA targeted probes and its app lication in fecal samples [J]. App l EnvironMicrobiol, 61 (8) : 3069～3075.
Lankaputhra W E V, Shan N P.1995. Survival of Lactobacillus Acidophilus andBifrdobacterium spp in the Presence of Acid and Bile Salts[J]. 30(3): 2~7.
Liu S W, Zhang Q X, Chen J D, et al. 2006. genetic diversity of avian infectious bronchitis coronavirus strain isolated in China between 1995 and 2004[J]. Arch Virol, 151: 1133～1148.
Leman A D, Straw B, Glock R D, et al . 1992. Disease of Swine [M]. 7thed. Ames: Iowa State University Press, 362～386.
MalinM,SuomalainenH, Sxaelin M.1996, 40.Pormotion of IgaA immune response in Patients with crohn’s disease by oral bacteriotherapy with Lacotbacllius GG. Ann. Nutr. Metab.137～145.
Maria S, Gunnar M, Rangne F, et al. 2000. Probiotic bacteria: safety, functional and technological properties [J]. Journal of Biotechnology, 84 : 197～215.
Matsuzkai, T, ChinJ.2000. Modulating immune resPonses with Probiotic bacteria[J]. Immuno lCell Biol, 78(l): 67～73.
McCracken V J. Simp son J M, Mackie R l, et al. 2001. Molecular ecologicalanalysis of dietary and antibioticinduced alterations of the mouse intestinalmicrobiota[J]. Nutrition, (3) : 1862～1870.
Midorikawa T, Abe R, Yamagata Y, et al. 1998. Isolation and characterization of cDNA encoding chicken egg yolk aminopeptidase Ey[J].Comparative Biochemistry and Physiology Part B, 119: 513～520.
Miguel B, Pharr G T, Wang C, et al. 2002 .The role of feline aminopeptidase Nasa receptor for infectious bronchitis virus[J]. Arch Virol, 147: 2047～2056.
MUYZER G. 1993. Profiling of comp lexmicrobial populations by denaturing gradient get electroporesis analysis of polymerase chain reaction amp lified genes encoding for 16S rRNA.[J]. App l EnvironMicrobiol, 59: 695～700.
Oberhelman R.A., GilmnaR.H.1999, 134. A Plaeebo-controlled trial of Laetobaeillus GG to Pervent diarrhea in undemourished Peruvian children[J]. J. Pediatr. 15～20.
Ouwehand AC,Salminen S, Isolauri E. 2002. Probiotics:an overview of beneficial effects [J]. Antonie Van Leeuwenhoek, 82(1～4): 279～289.
Perdigon D, Valdez J C, Rachid M. 1998, 65. Antitumour activity of yogurt: Study of possible Immune meehanisms. J. Dairy Reseacrh., 129～138.
Paul S M. 2006. The molecular biology of coronavirues[J]. Advances In Virus Research, 66 : 193～292.
Raos, Hus,Mchughl, et al. 2005. Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide [J]. PNAUSA, 102 (34) : 11993～11998.
Roa C.V, Snaders M.E., Indnarie C.1999, 14(5). Pervention of colonic PerneoPlastie lesions By the Probiotic Lacotbacillus acidophilus NCFMTM in F344 rats [J]. Int.Oncol. 939～944.
Saarela M, Lahteennmaki L, Crittenden R et al. 2002. Gut bacteria and health foods-the European perspective[J]. International Journal of Fond Microbiology, 78(1,2): 99～117.
Sara A, Ander I, Isabe S, et al. 2002 .Transcription regulatory sequences and mRNAexperssion levels in the coronavirus transmissible gast roenteritis virus [J]. J Virol, 76 (3) : 1293～1308.
Sihn G, Savary K, Michaud A, et al. 2006. Aminopeptidase N during the ontogeny of the chick[J]. Differentiation, 74: 119～128.
Sun L, Zhang G H , Jiang J W, et al. 2007. A Massachusetts prototype like coronavirus is olatedfrom wild peafowls is pathogenic to chicken s[J] . Virus Research, 130(1～2) : 121～128.
Tannock G W. 1988. New concept s in haelth promotion [J].The Normal Microflora, 5 (1) : 4～8.
Tanja Boti? a, Trine Dan?′Klingberg b, Hana Weingartl c, et al. 2007. A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria[J]. International Journal of Food Microbiology, 115 : 227–234.
Tannock G W. 1988. New concepts in haelth promotion [J] .The Normal Microflora, 5 (1) : 4～8.
Tao. 2004. http: / /hivworkshop. com /may 042321. htm
Tannockgw, Munrok, Harmsenhjm, et al. 2000.Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20[J]. App l Environ Microbiol, 66 (6) : 2578～2588.
Thierry Gonzales. 1996. Bacterial aminopeptidases: Properties and functions[J]. FEMS Microbiology Reviews, (18) : 319～344.
TomoakiTanaka, EijiIchishima. 1993. Molecular Properties of Aminopeptidase Eyas a Zinc～metalloenzyme[J]. Biochem.Vol 25:1681～1688.
Watanabe T, Hotta C. 1996. Enhancement of host resistance to microbial infections in mice fed a high fat diet by Lactobacillus casei cells[J]. Hiroshima J. Med. Sci, 45(2): 63～68.
Weingartl H M, Derbyshire J B. 1993.Binding of porcine transmissible gastroenteritis virus by enterocytes from weaned piglets[J]. Vet Microbiol, 35 :23～32.
Wilsonkh, Blitchingtonrb.1996. Human colonic biota studied by ribosomal DNA sequence analysis.[J]. App l Environ Microbil, 62 (7) : 2273～2278.
Winter C, H errler G, Neumann U. 2008. Infection of the tracheal epithelium by infectious bronchitis virus is sialicacid dependent[J] . Microbes and Infection, 10(4) : 367～373.
Zhang Chunyang.2007. Current clinical study status of microecological preparations [J]. Progress in Modem Biomedicine, 7(6): 926～929(In Chinese).
Ziemer C J, Gleen R G. 1998. Anov review of probioties, prebioties and synbioties in the funetion afood eoncept: perspeetive and foture[J]. Int DairyJ, 8: 473~479.
程杰,柳纪省,吴润,等. 2003.猪传染性胃肠炎病毒的分子生物学研究进展[J]. Chinese Journal of Veterinary Science and Technology, 33(12), 36～37.
程伶摘译. 1995.家畜肠道细菌与生产性能的关系[J].国外畜牧技, 22(2): 13～16.
戴国荣,曹国文,姜永康等.2005.不同芽孢杆菌组合对仔猪生产性能的影响[J].营养与饲料,8: 53～54.
方定一, 1980.大肠杆菌对仔猪所致肠道疾病与防治[J].江苏农学报. 1(1): 1～7.
郭崇志,宣振宇. 2002 .人脯氨肽酶活性中心结构的计算机模拟.中国生物化学与分子生物学报, 18 (4) : 499～505.
郭延军.2001.乳杆菌制剂治疗雏鸡白痢效力的研究[J].河北畜牧兽医,17(2): 16～17.
郭云霞,王树香,郝庆红,等. 2009.动物肠道微生态系统及益生菌的营养功能[J].饲料研究, 6: 24～25.
郭兴华. 2002.益生菌基础与应用[M].北京:北京科学技术出版社, 159 : 256～261.
何明清. 1994.动物微生态学[J].北京:中国农业出版社, 48～50.
何明清. 1985.对猪只不同日龄及不同肠段正常菌群的研究[J].畜牧兽医学报, 16(2): 243～249.
何明清. 1994.动物微生态学.农业出版社, 89～95.
何明清. 1984.促菌生防治雏鸡白痢的实验研究及防治效果的观察[J].大连医学院学报, 6 (1): 106～112.
何明清等. 1980.仔猪黄痢及其生物制剂预防方法研究[J] .四川农业科技, 5: 26～28.
何明清,谢镜怀,朱玉兰等. 1985.对鸡只不同日龄不同肠段正常菌群的研究[J] .畜牧兽医学报, 16(5): 22～24.
何昭阳,王增辉,吴延春. 2000.雏鸡消化道主要正常菌群定植规律的研究[J] .畜牧兽医学报, 31(1): 42～48.
黄祯祥主编. 1990.医学病毒学基础及实验技术[J].北京:科学出版社, 151～152.
黄承凤. 1998.饲用益生素[J].中国饲料, 2: 24～25.
黄沧海. 2003.仔猪复合益生乳酸杆菌制剂及其作用机理的研究[D].北京:中国农业大学.
黄海,张清敏,徐建设等. 2009.复合益生菌体外抑菌杀病毒作用研究[J].中国微生态学杂志, 21 (1): 30～35.
金梅林,陈焕春,何启盖等.1998.传染性支气管炎病毒在鸡胚成纤维细胞中适应及复制的生物学特性研究[J].中国兽医杂志, 24(11): 3～4.
金鹏. 2009.益生菌研究进展.农产品加工, 70.
金世琳. 1999.双歧杆菌的功能一健康科学的探索[J].中国乳品工业, 27(3): 41～42.
赖庆安,刘树滔,卢菀华. 2008.鸡氨肽酶H在大肠杆菌中的表达、纯化与部分酶学性质[J].生物工程学报, March 25; 24(3): 381～386.
雷蕾,张日俊. 2008.鸡肠道正常菌群的研究进展. Chinese Journal of Microecology, 20(3): 298～299.
李华, 1999.传染性支气管炎分子生物学研究进展[J].中国兽医杂志, 25(1) : 46~ 48.
李健雄,邝哲师,田兴山. 2004.微生态制剂的研究与应用进展[J].广东畜牧兽医科技, 4: 15～17.
刘冰心,曹敏杰,蔡秋凤,等. 2008.草鱼肌肉亮氨酸氨肽酶的分离纯化与性质研究[J]. 集美大学学报, 13(1): 24～25.
刘博奇,李广兴,王衡,等. 2009.猪传染性胃肠炎病毒特异性受APN功能区的初步鉴定[J].黑龙江畜牧兽医, 21～23.
刘燕,王静慧. 2002.微生态学理论和我国动物微生态制剂研究现状[J].中国兽药杂志, 36 (8) : 38.
罗群力,李静雅,叶其壮,等. 2004.甲硫氨酞氨肤酶的研究进展[J].中国药学杂志, 39(11): 804～805.
明晓波,魏萍. 2008.鸡产染性支气管炎病毒受体的研究进展[J].动物医学进展. 3(29): 82～83.
那日苏,桂荣,等. 2002,牛用益生素的研究与应用[J].饲料研究, 12: 10～13.
那日苏,等. 2004.酵母培养物对绵羊瘤胃发酵及生产性能的影响[J].中国畜牧兽医, 31(1): 6～9.
聂志武. 1998.饲用益生菌[J].中国饲料, 5: 9～10.
潘康成,吕道俊,何明清.正常菌群对动物免疫功能的影响研究[J].
彭勇,李文魁. 1999.国外抗流感病毒植物药研究近况[J].国外医药植物药分册, 14(1): 7～9.
沈志勇,牛钟相,彭军等. 2003.鸡消化道正常菌群的研究进展[J],动物医学进展. 24(6): 61～63.
王君. 2007.微生态制剂研究进展与应用现状[J] .现代畜牧兽医, (1): 52～54.
王桂瑛,刘燕. 2004.益生素的研究及应用进展[J].饲料博览, (6): 4～6.
王健,于景华,张国钮等. 2005.益生菌促生长因子的筛选[J].中国乳品工业, 33(6): 10～12.
王桂瑛,刘燕. 2004.益生素的研究及应用进展[J],饲料博览, 6: 4～6.
王建华. 2005.新型安全饲料添加剂的研制与开发[M].北京:科学技术出版社, 256～262.
温彩霞. 2003.复合型菌剂对鸡白痢菌的抑制作用及其各菌在鸡体内定居情况[J].中国微生态杂志, 5(1): 28～32.
温彩霞. 2002.抗鸡白痢益生菌株的筛选[J].中国微生态杂志, 14(6): 34～36.
吴惠芬,毛胜勇,姚文,等. 2005. 2株猪源乳酸菌对低pH值和胆盐耐受性及热稳定性研究[J] .华中农业大学学报, 24 (3) : 265～268.
吴惠芬. 2003.猪源乳酸菌的分离鉴定及其益生作用研究[D].南京:南京农业大学.
杨景云.肠道菌群与健康肠道微生态学[M].哈尔滨:黑龙江科技出版社, 1991: 135.
殷震主编. 1997.动物病毒学[M] .科学出版社, 675~ 683.
殷震,刘景华. 1997.动物病毒学[M] .第2版.北京:科学出版社, 681～688.
余叶红,郭本恒,吴正钧,等. 2009.干酪乳杆菌LC2W细胞壁组分对RAW264.7巨噬细胞吞噬活性的影响[J].中国微生态学杂志, 21: 123～29.
袁铁铮,姚斌. 2003.分子水平上益生菌研究进展[J].中国生物工程杂志, 24 (10): 27～33.
岳寿松. 2003.微生态制剂对奶牛增奶的实验研究[J].中国奶牛, (3): 20:21.
曾祥伟. 2006. IBV组织嗜性差异分析及其诱导细胞凋亡的研究[D].黑龙江哈尔滨:东北农业大学, 79～81.
张龙涛,冯玉兰,刘波,等.饲用益生菌研究进展[J].食品安全的理论与实践, 275.
张子仪. 2000.中国饲料学[M].北京:中国农业出版社.
张润栋. 1998.活菌制剂在畜禽饲养业中的应用[J].饲料博览, 10(1): 21～25.
赵香汝,赵彦雪,杨玉成. 2005 .中药病毒克颗粒剂对鸡新城疫的预防与治疗效果的观察[J ] .中兽医学杂志, 127(6): 6～7.
Apajalahti, Kettunen, Nurmin, et a. 2003.Selectivep lating underestimetes abundance and shows differential recovery of bifidobacterial species from human feces .[J]. App l Environ Microbiol, 69.
Ariaans M P. 2008. The role of phagocyti cells in enhanced susceptibility of broilers to col ibacillosis after infectious bronchit is virus infection [M]. Vet Immunol Immunopathol, InPress, C or rected Proof , Availab leonline 16 eruary.
AlmazanF, Penze Z. 2001.Cloning of at ransmissible gast roenteritis coronavirus full length cDNA.[J]. Adv Exp Med Biol, 494 : 533～536.
Annuk H, Shchepetova J, Kullisaar T, et al . 2003 . Characterization of intestnal Lactobacilli as putative probiotic candidates[J ]. Journal of Applied Microbiology, 94 : 403～412.
Boursnell M E, et al . 1987. Completion of the sequence of the genome of the coronavirus avian infectious bronchit is virus[ J] . J. Gen.Virol , 68: 57~ 77.
Collinsmd, Gibson G R. 1999. Prebiotics and synbiotics: app roaches formodulation the microbial ccology of the gut [J]. Clin Nutr, 69 (5) : 1052~1057.
Chu V C, Mcelroy L J, Aronson J M, et al. 2007. Feline aminopeptidase N is not a functional receptor for avian infectious bronchitis virus[J].Virology Journal, 4: 20～29.
Chousalkar K K, Roberts J R. 2007. Ultrastructural study of inf ectious bronchit is virus infection in infundibulum and magnum of commercial laying hens .[J] . Vet Microbiol, 122 (3～4): 223～236.
Chen C M, Cavanagh B P. 1995. Cloning and sequencing of a 8.3 kb region f rom the 3′-end of Taiwanese virulent isolate of the coronavirus transmissible gast roenteritis virus[J] . Virus Res , 38 (1) : 83～89.
CrossM.L. 2002. Immunoregulation by Probiotic Lactobacili:Por-Thl singals and their relevnace to humna health. Clin. APPI. Immunol. Rev. 115.
DONSKEY C J, HUJER A M, DAS SM, et al. 2003. Use of denaturing gradient gelelectrophresis for analysis of the stool microbiota of hospintalized Patients [J]. Microbiol Methods, 39 (2) : 249～256.
Dnaiel J.O’Sullivna. 2001. 49. Seerening of intestinal microflora for effctive Probiotie bacteria.J.Agrie. FoodChem. 1751～1760.
Doleyers.Y.2002, 60. Bifibacetrium longumATCC15707 cell Porduction during free and Immobilized-cell culutres in MRS-whey Permeate medium. APPI Mierobiol Bioteehnol. 168～173.
Eiji Ichishima,Youhei Yamagata, Hideki Chiba Kazuyo Sawqguchi,Tomoaki Tanaka. 1989.
Soluble and Bound Forms of Aminopeptidase in Hen’s Egg Yolk.Agric.Biol.Chem [J], 53(7): 1870～1872.
Ehrmann M A , Kurzak P, Bauer J, et al . 2002 . Characterization of lactobacilli towards their use as probiobics adjuncts in poultry[J ] . Journal of Applied Microbiology, 92 : 966～975.
Florenece C G, SandraM L, Bruno B, et al. 2007. Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria[J]. Microbes and Infection , 9: 1623～1631.
Fang S G, Chen N, Felicia P L, et al. 2007. An argininets proline mutation in a domain with undefined functions within the helicase protein (Nsp13) is lethal to the coronavirus infectious bronchit is virus incultured cells[J]. Virology, 358(1) : 136～147.
Florenece C G, SandraM L, Bruno B, et al. 2007. Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria[J]. Microbes and Infection, 9: 1623～1631
Fuller R. 1989. Probiotics in Man and Animals[J]. Appl. Bacterio. 66: 365～378.
Guarnerf, Malageladajr. 2003. Gut flora in health and disease [J]. Lancet, 361: 512～519.
Gregor R. 1999. The scientific basis for probiotic strains of L actobacillus[J] . Applied and Environmental Microbiology, 65(9): 3763～3766.
Harrison S M , Dove B K, Rothw ell L, et al. 2007.Characterisati on of cyclin D1 down or regulation in coronavirus infected cells[J]. FEBS Letters, 581(7) : 1275～1286.
Haberer P, Dutoit M, Dicks L, M, T, Ahrs F. 2003, 27. Eeffet of Potetilly Porbioti Laetobacilli on feacal enzyme aetivity in minipigs on a high fat, highcholesterol dieta perliminary in vivortial. Ini. Food. Miero. l～5 .
Hood S K, Zottola E A. 1988. Effect of low pH on the Ability of Lactobacillus Acidophilus to Survive and Adhere to Human Intestinal Cells[J]. Journal of Food Science. 53: 1514～1516.
Jean Francois E, Denis R, Patnck L, et al . 1995.Complete sequence ( 20 kilobase ) of the Ployprotein encoding gene 1 of transmissible gastroenteritis virus [J]. J Virol , 206 : 817～822.
Kopp HoolihnaL. 2001. prophylaeitic and theraPeutic uses of Probioties[J]. A review Amer, Dlet. Assoe ,101(2): 229～241.
Landend Ijkps, Schutf, Jansen G J, et al. 1995.Quantitative fluorescence in situ hybridation of bifidobacterium spp. with genus specific 16S rRNA targeted probes and its app lication in fecal samples [J]. App l EnvironMicrobiol, 61 (8) : 3069～3075.
Lankaputhra W E V, Shan N P.1995. Survival of Lactobacillus Acidophilus andBifrdobacterium spp in the Presence of Acid and Bile Salts[J]. 30(3): 2~7.
Liu S W, Zhang Q X, Chen J D, et al. 2006. genetic diversity of avian infectious bronchitis coronavirus strain isolated in China between 1995 and 2004[J]. Arch Virol, 151: 1133～1148.
Leman A D, Straw B, Glock R D, et al . 1992. Disease of Swine [M]. 7thed. Ames: Iowa State University Press, 362～386.
MalinM,SuomalainenH, Sxaelin M.1996, 40.Pormotion of IgaA immune response in Patients with crohn’s disease by oral bacteriotherapy with Lacotbacllius GG. Ann. Nutr. Metab.137～145.
Maria S, Gunnar M, Rangne F, et al. 2000. Probiotic bacteria: safety, functional and technological properties [J]. Journal of Biotechnology, 84 : 197～215.
Matsuzkai, T, ChinJ.2000. Modulating immune resPonses with Probiotic bacteria[J]. Immuno lCell Biol, 78(l): 67～73.
McCracken V J. Simp son J M, Mackie R l, et al. 2001. Molecular ecologicalanalysis of dietary and antibioticinduced alterations of the mouse intestinalmicrobiota[J]. Nutrition, (3) : 1862～1870.
Midorikawa T, Abe R, Yamagata Y, et al. 1998. Isolation and characterization of cDNA encoding chicken egg yolk aminopeptidase Ey[J].Comparative Biochemistry and Physiology Part B, 119: 513～520.
Miguel B, Pharr G T, Wang C, et al. 2002 .The role of feline aminopeptidase Nasa receptor for infectious bronchitis virus[J]. Arch Virol, 147: 2047～2056.
MUYZER G. 1993. Profiling of comp lexmicrobial populations by denaturing gradient get electroporesis analysis of polymerase chain reaction amp lified genes encoding for 16S rRNA.[J]. App l EnvironMicrobiol, 59: 695～700.
Oberhelman R.A., GilmnaR.H.1999, 134. A Plaeebo-controlled trial of Laetobaeillus GG to Pervent diarrhea in undemourished Peruvian children[J]. J. Pediatr. 15～20.
Ouwehand AC,Salminen S, Isolauri E. 2002. Probiotics:an overview of beneficial effects [J]. Antonie Van Leeuwenhoek, 82(1～4): 279～289.
Perdigon D, Valdez J C, Rachid M. 1998, 65. Antitumour activity of yogurt: Study of possible Immune meehanisms. J. Dairy Reseacrh., 129～138.
Paul S M. 2006. The molecular biology of coronavirues[J]. Advances In Virus Research, 66 : 193～292.
Raos, Hus,Mchughl, et al. 2005. Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide [J]. PNAUSA, 102 (34) : 11993～11998.
Roa C.V, Snaders M.E., Indnarie C.1999, 14(5). Pervention of colonic PerneoPlastie lesions By the Probiotic Lacotbacillus acidophilus NCFMTM in F344 rats [J]. Int.Oncol. 939～944.
Saarela M, Lahteennmaki L, Crittenden R et al. 2002. Gut bacteria and health foods-the European perspective[J]. International Journal of Fond Microbiology, 78(1,2): 99～117.
Sara A, Ander I, Isabe S, et al. 2002 .Transcription regulatory sequences and mRNAexperssion levels in the coronavirus transmissible gast roenteritis virus [J]. J Virol, 76 (3) : 1293～1308.
Sihn G, Savary K, Michaud A, et al. 2006. Aminopeptidase N during the ontogeny of the chick[J]. Differentiation, 74: 119～128.
Sun L, Zhang G H , Jiang J W, et al. 2007. A Massachusetts prototype like coronavirus is olatedfrom wild peafowls is pathogenic to chicken s[J] . Virus Research, 130(1～2) : 121～128.
Tannock G W. 1988. New concept s in haelth promotion [J].The Normal Microflora, 5 (1) : 4～8.
Tanja Boti? a, Trine Dan?′Klingberg b, Hana Weingartl c, et al. 2007. A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria[J]. International Journal of Food Microbiology, 115 : 227–234.
Tannock G W. 1988. New concepts in haelth promotion [J] .The Normal Microflora, 5 (1) : 4～8.
Tao. 2004. http: / /hivworkshop. com /may 042321. htm
Tannockgw, Munrok, Harmsenhjm, et al. 2000.Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20[J]. App l Environ Microbiol, 66 (6) : 2578～2588.
Thierry Gonzales. 1996. Bacterial aminopeptidases: Properties and functions[J]. FEMS Microbiology Reviews, (18) : 319～344.
TomoakiTanaka, EijiIchishima. 1993. Molecular Properties of Aminopeptidase Eyas a Zinc～metalloenzyme[J]. Biochem.Vol 25:1681～1688.
Watanabe T, Hotta C. 1996. Enhancement of host resistance to microbial infections in mice fed a high fat diet by Lactobacillus casei cells[J]. Hiroshima J. Med. Sci, 45(2): 63～68.
Weingartl H M, Derbyshire J B. 1993.Binding of porcine transmissible gastroenteritis virus by enterocytes from weaned piglets[J]. Vet Microbiol, 35 :23～32.
Wilsonkh, Blitchingtonrb.1996. Human colonic biota studied by ribosomal DNA sequence analysis.[J]. App l Environ Microbil, 62 (7) : 2273～2278.
Winter C, H errler G, Neumann U. 2008. Infection of the tracheal epithelium by infectious bronchitis virus is sialicacid dependent[J] . Microbes and Infection, 10(4) : 367～373.
Zhang Chunyang.2007. Current clinical study status of microecological preparations [J]. Progress in Modem Biomedicine, 7(6): 926～929(In Chinese).
Ziemer C J, Gleen R G. 1998. Anov review of probioties, prebioties and synbioties in the funetion afood eoncept: perspeetive and foture[J]. Int DairyJ, 8: 473~479.